Macrophages protect against loss of adipose tissue during cancer cachexia
Abstract Background Cancer cachexia represents a central obstacle in medical oncology as it is associated with poor therapy response and reduced overall survival. Systemic inflammation is considered to be a key driver of cancer cachexia; however, clinical studies with anti‐inflammatory drugs failed...
Saved in:
Main Authors: | Merve Erdem (Author), Diana Möckel (Author), Sandra Jumpertz (Author), Cathleen John (Author), Athanassios Fragoulis (Author), Ines Rudolph (Author), Johanna Wulfmeier (Author), Jochen Springer (Author), Henrike Horn (Author), Marco Koch (Author), Georg Lurje (Author), Twan Lammers (Author), Steven Olde Damink (Author), Gregory van derKroft (Author), Felix Gremse (Author), Thorsten Cramer (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammation‐associated intramyocellular lipid alterations in human pancreatic cancer cachexia
by: Min Deng, et al.
Published: (2024) -
Progesterone improves survival in hepatoma cachexia rat model
by: Tsuyoshi Suzuki, et al.
Published: (2020) -
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
by: Jochen Springer, et al.
Published: (2023) -
The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
by: Luping Yuan, et al.
Published: (2023) -
Body weight changes and incidence of cachexia after stroke
by: Nadja Scherbakov, et al.
Published: (2019)